Sargent Bickham Lagudis’s iShares US Medical Devices ETF IHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $98K | Buy |
1,865
+1,265
| +211% | +$66.5K | 0.01% | 337 |
|
|
2022
Q3 | $28K | Sell |
600
-193
| -24% | -$9.01K | ﹤0.01% | 516 |
|
|
2022
Q2 | $40K | Buy |
793
+1
| +0.1% | +$50 | ﹤0.01% | 466 |
|
|
2022
Q1 | $49K | Hold |
792
| – | – | ﹤0.01% | 457 |
|
|
2021
Q4 | $52K | Hold |
792
| – | – | ﹤0.01% | 440 |
|
|
2021
Q3 | $50K | Hold |
792
| – | – | ﹤0.01% | 443 |
|
|
2021
Q2 | $48K | Hold |
792
| – | – | ﹤0.01% | 458 |
|
|
2021
Q1 | $44K | Hold |
792
| – | – | ﹤0.01% | 456 |
|
|
2020
Q4 | $43K | Buy |
792
+192
| +32% | +$10.4K | ﹤0.01% | 451 |
|
|
2020
Q3 | $30K | Hold |
600
| – | – | ﹤0.01% | 451 |
|
|
2020
Q2 | $26K | Hold |
600
| – | – | ﹤0.01% | 448 |
|
|
2020
Q1 | $23K | Buy |
+600
| New | +$23K | ﹤0.01% | 443 |
|